Susquehanna International Group
CLGN icon

Susquehanna International Group’s CollPlant Biotechnologies CLGN Stock Holding History

Susquehanna International Group’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,058
Closed -$173K – 13062
2021
Q4 		$173K Buy
+1,058
New +$189K ﹤0.01% 11620

Other funds holding CLGN

RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
IMOV
Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group's CLGN Position: Q1 2022 in Review

Susquehanna International Group sold out of CollPlant Biotechnologies (CLGN) in Q1 2022, closing a stake of 1,058 shares — an estimated $173K sold.

Susquehanna International Group first reported a position in CLGN in Q4 2021 and held it in 1 quarter. The position peaked at $173K in Q4 2021. 16 funds tracked by Wall St. Rank hold CLGN as of Q1 2022.

  • Susquehanna International Group reported no remaining CollPlant Biotechnologies position as of Q1 2022 after selling out during the quarter.
  • Susquehanna International Group sold 1,058 CollPlant Biotechnologies shares in Q1 2022, an estimated $173K.
  • Susquehanna International Group first reported a position in CollPlant Biotechnologies in Q4 2021 and held it in 1 quarter.
  • Susquehanna International Group's CollPlant Biotechnologies position peaked at $173K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.